UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Identification of Human Neutralization-Inducing Regions of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins

Proceedings of the National Academy of Sciences - PNAS, 1992-01, Vol.89 (2), p.461-465

1992

Volltextzugriff (PDF)

Presence of Maternal Antibodies to Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 Epitopes Correlates with the Uninfected Status of Children Born to Seropositive Mothers

Proceedings of the National Academy of Sciences - PNAS, 1989-10, Vol.86 (20), p.8055-8058

1989

Volltextzugriff (PDF)

Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers

The Journal of infectious diseases, 1990-02, Vol.161 (2), p.198

1990

Volltextzugriff (PDF)

Antibody‐dependent cellular cytotoxicity and neutralizing activity in sera of HIV‐1‐infected mothers and their children

Clinical and experimental immunology, 1993-07, Vol.93 (1), p.56-64

1993

Volltextzugriff (PDF)

Human MoAbs produced from normal, HIV‐1‐negative donors and specific for glycoprotein gp 120 of the HIV‐1 envelope

Clinical and experimental immunology, 2008-06, Vol.89 (2), p.290-295

2008

Volltextzugriff (PDF)

Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160

Journal of acquired immune deficiency syndromes (1988), 1994-03, Vol.7 (3), p.220-229

1994

Volltextzugriff (PDF)

IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages

Clinical and experimental immunology, 1988-09, Vol.73 (3), p.343-347

1988

Volltextzugriff (PDF)

Mutation in the TACI gene and autoimmune neutropenia: A case report

American journal of hematology, 2022-06, Vol.97 (6), p.E207-E210

2022

Volltextzugriff (PDF)

Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease

Bone marrow transplantation (Basingstoke), 2004-10, Vol.34 (7), p.589-593

2004

Volltextzugriff (PDF)

Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies

Journal of acquired immune deficiency syndromes (1988), 1994-09, Vol.7 (9), p.940-951

1994

Volltextzugriff (PDF)

Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients

Clinical and experimental immunology, 1989-05, Vol.76 (2), p.216-221

1989

Volltextzugriff (PDF)

A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization

Journal of Virology, 1990-02, Vol.64 (2), p.936-940

1990

Volltextzugriff (PDF)

Human MoAbs produced from normal, HIV-1 negative donors and specific for glycoprotein gp120 of the HIV-1 envelope

Clinical and experimental immunology, 1992-08, Vol.89 (2), p.290-295

1992

Volltextzugriff (PDF)

Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency

AIDS (London), 1990-04, Vol.4 (4), p.291-295

1990

Volltextzugriff (PDF)

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

Blood, 2002-08, Vol.100 (3), p.768-773

2002

Volltextzugriff (PDF)

Diagnostic implication of specific immunoglobulin G patterns of children born to HIV-infected mothers

AIDS (London), 1989-09, Vol.3 (9), p.577-582

1989

Volltextzugriff (PDF)

Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2

AIDS research and human retroviruses, 1991, Vol.7 (1), p.97-101

1991

Volltextzugriff (PDF)

Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection

Journal of acquired immune deficiency syndromes (1988), 1991, Vol.4 (10), p.952-958

1991

Volltextzugriff (PDF)

Identification of B-cell antigenic sites on HIV-2 gp125

Journal of acquired immune deficiency syndromes (1988), 1992, Vol.5 (2), p.177-187

1992

Volltextzugriff (PDF)

HIV-1-specific antibodies in cerebrospinal fluid mediate cellular cytotoxicity and neutralization

AIDS research and human retroviruses, 1989-12, Vol.5 (6), p.629-638

1989

Volltextzugriff (PDF)

Analyses of functional antibody responses in HIV-1-infected individuals after vaccination with rgp160

Clinical and diagnostic virology, 1996-08, Vol.6 (2), p.115-126

1996

Volltextzugriff (PDF)

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120

AIDS (London), 1990-10, Vol.4 (10), p.953-960

1990

Volltextzugriff (PDF)

A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates

Journal of acquired immune deficiency syndromes and human retrovirology, 1996-07, Vol.12 (3), p.221

1996

Volltextzugriff (PDF)

Mother-to-infant transmission of HIV

The Lancet (British edition), 1990-02, Vol.335 (8685), p.359-360

1990

Volltextzugriff (PDF)

A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxocity and neutralization

Journal of virology, 1990, Vol.64 (2), p.936-940

1990

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Humans
(59)
Life Sciences & Biomedicine
(57)
Medicin Och Hälsovetenskap
(56)
Female
(36)
Immunology
(35)
Infectious Diseases
(33)
Biological And Medical Sciences
(32)
Aids/hiv
(30)
Virology
(27)
Male
(26)
Adult
(25)
Hiv-1 - Immunology
(22)
Medical Sciences
(22)
Hiv
(21)
Microbiology
(18)
Hiv Infections - Immunology
(17)
Human Immunodeficiency Virus
(16)
Human Immunodeficiency Virus 1
(15)
Fundamental And Applied Biological Sciences. Psychology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of Human Neutralization-Inducing Regions of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins

Presence of Maternal Antibodies to Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 Epitopes Correlates with the Uninfected Status of Children Born to Seropositive Mothers

Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers

Antibody‐dependent cellular cytotoxicity and neutralizing activity in sera of HIV‐1‐infected mothers and their children

Human MoAbs produced from normal, HIV‐1‐negative donors and specific for glycoprotein gp 120 of the HIV‐1 envelope

Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160

IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages

Mutation in the TACI gene and autoimmune neutropenia: A case report

Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease

Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies

Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients

A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization

Human MoAbs produced from normal, HIV-1 negative donors and specific for glycoprotein gp120 of the HIV-1 envelope

Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

Diagnostic implication of specific immunoglobulin G patterns of children born to HIV-infected mothers

Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2

Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection

Identification of B-cell antigenic sites on HIV-2 gp125

HIV-1-specific antibodies in cerebrospinal fluid mediate cellular cytotoxicity and neutralization

Analyses of functional antibody responses in HIV-1-infected individuals after vaccination with rgp160

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120

A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates

Mother-to-infant transmission of HIV

A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxocity and neutralization

Aktive Filter

Suchergebnisse filtern